Radnet has announced that it is using AI to offer patients more detailed breast screening examinations as part of its Enhanced Breast Cancer Detection (EBCD) service. The new service will enable women attending their annual breast screening examinations to, for an additional fee, receive additional services which include the use of AI tools to assess a woman’s lifetime breast cancer risk.

EBCD utilises the Saige-Dx, a US-FDA cleared mammography diagnostic aid software from DeepHealth (a RadNet acquired company), adds an additional review applied to any suspicious